Vol 5, No 5 (2016)
Research paper
Published online: 2017-02-03

open access

Page views 879
Article views/downloads 939
Get Citation

Connect on Social Media

Connect on Social Media

An attempt to identify factors determining the prevalence and intensity of depression in patients with diabetes in Polish population — preliminary report

Marek Wojtaszek, Marta Król, Dorota Ozga, Elżbieta Mach- Lichota, Krystyna Woźniak
Clin Diabetol 2016;5(5):141-146.

Abstract

Introduction. Diabetes is included in the group of metabolic diseases. According to the estimates of the World Health Organization (WHO) the global number of patients suffering from diabetes has increased to 387 million in just 11 years. 5% of Polish society, which is about 2 million, is diagnosed with this particular illness in Poland. Metabolic disorders occur 2 to 3 times more often in patients with mental diseases than in the general population. Often diabetes is accompanied by depression making it a chronic illness.

Aim. The aim of the study is to identify factors determining the prevalence and intensification of depression in patients suffering from diabetes.

Material and methods. The study included 100 patients with diabetes in the Subcarpathian region, who are being treated in specialist clinics. The study was conducted from 12th to 20th April 2016 using an original questionnaire. Verification of differences was performed by means of chi-square test of independence and U Manna-Whitney test, applying the significance level at p < 0.05. Calculations were performed using SPSS.

Results. The average age of the respondents was 41.25 years, SD = 15.38. The prevalence of depression in family history was pointed by 31% of responders and 40.0% of them declared permanent psychiatric consultations. Depression was diagnosed in 25.0% of the diabetic patients. Among the symptoms observed the respondents enumerated fatigue, lack of energy, lack of motivation to make any effort (60.0%). Depression was treated more often among patients treated for diabetes for over 20 years (53.8%).

Conclusions. The prevalence of depression symptoms was observed by all of the patients in the study. The most common ones included fatigue, lack of energy and lack of motivation to make any effort. More men than women stated that they were consulting a psychiatrist. The patients who suffered from diabetic complications are more eager to consult a psychiatrist and undergo the treatment for depression. Fluctuations of blood glucose may have an impact on depression symptoms in diabetic patients.  

Article available in PDF format

View PDF Download PDF file

References

  1. Wojciechowski P. Edukacja w cukrzycy. Raport diabetologiczny. 2015; 1: 18–42.
  2. Zimmet PZ, Magliano DJ, Herman WH, et al. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014; 2(1): 56–64.
  3. Janeczko D. Epidemiologia chorób układu krążenia u chorych na cukrzycę. Kardiologia Na Co Dzień. 2007; 2: 12–16.
  4. Karolina J, Jaślikowska U, Zbrojkiewicz M, Ślusarska B et al. Czynniki związane z występowaniem depresji u osób dorosłych. Przegląd systematyczny literatury polskiej w latach 2009–2014.
  5. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003; 54(3): 216–226.
  6. Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24(6): 1069–1078.
  7. Carney RM, Freedland KE, Miller GE, et al. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002; 53(4): 897–902.
  8. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003; 54(3): 227–240.
  9. Ziółkowska-Kochan M, Pracka D. Depresja po udarze mózgu. Psychiatria w Praktyce Ogólnolekarskiej. 2003; 3: 203–208.
  10. Wichowicz HM, Sławek J, Derejko M, et al. Factors associated with depression in Parkinson's disease: a cross-sectional study in a Polish population. Eur Psychiatry. 2006; 21(8): 516–520.
  11. Nowicki A, Rządkowska B. Depresja i lęk u chorych z nowotworami złośliwymi. Współczesna Onkologia. 2005; 9: 396–403.
  12. Potyralska MM, Krawczyk AM. Depresja u osób z cukrzycą typu 2 — współwystępowanie, implikacje kliniczne i terapeutyczne. Wiadomości Lekarskie. 2007; 60: 449–453.
  13. Lustman PJ, Griffith LS, Clouse RE, et al. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis. 1986; 174(12): 736–742.
  14. Everson SA, Maty SC, Lynch JW, et al. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res. 2002; 53(4): 891–895.
  15. Musselman DL, Betan E, Larsen H, et al. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003; 54(3): 317–329.
  16. Eaton WW, Armenian H, Gallo J, et al. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996; 19(10): 1097–1102.
  17. Carnethon MR, Biggs ML, Barzilay JI, et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med. 2007; 167(8): 802–807.
  18. Duda-Sobczak A, Wierusz-Wysocka B. [Diabetes mellitus and psychiatric diseases]. Psychiatr Pol. 2011; 45(4): 589–598.
  19. Von Korff M, Katon W, Lin EHB, et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004; 27(4): 914–920.
  20. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care. 2000; 23(10): 1556–1562.
  21. Kinder LS, Kamarck TW, Baum A, et al. Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms. Health Psychol. 2002; 21(6): 542–552.
  22. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications. 2005; 19(2): 113–122.
  23. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160(14): 2101–2107.
  24. Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002; 288(4): 475–482.
  25. Kurowska K, Strzesak E, Głowacka M, et al. Depresyjność a poczucie koherencji u osób z rozpoznaniem typu 2 cukrzycy. Psychogeriatria Polska. 2009; 6: 1–7.
  26. Lerman I, Lozano L, Villa AR, et al. Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City. Biomed Pharmacother. 2004; 58(10): 566–570.
  27. Park H, Hong Y, Lee H, et al. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol. 2004; 57(9): 978–984.
  28. Abrahamian H, Hofmann P, et al. Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatric Disease and Treatment. 2009: 261–266.
  29. Majchrzak A, Pietrzykowska E, Zozulińska-Ziółkiewicz D, et al. Wpływ typu osobowości na poziom depresji i wyrównanie metaboliczne u chorych na cukrzycę typu 1. Diabetologia Praktyczna. 2009; 10: 85–91.
  30. Kurpas D, Kusz J, Jedynak T, et al. The acceptance level of chronic diseases among patients. Family Medicine & Primary Care Review. 2012; 14: 396–398.
  31. Haor B, Gołębiewska A, Głowacka M, et al. Selected aspects of acceptance of chronic disease in patients of type 2 diabetes. Zeszyty Naukowe WSHE. Zeszyty Naukowe WSHE. 2013; XXXVII: 93–104.